Skorpios Trust
CIK
1869333
Location
LIMASSOL, G4
Portfolio Value
Micro
$53,020,253
Diversification
Highly concentrated
Filing Date
Global Rank
#6,489
/ 7,976
▲ 304
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+12.7%
Period ended 9 months ago
Filed Oct 29, 2025 · 8mo
16 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+138.0%
SPY
+76.3%
Annualised alpha
+12.7%
Max drawdown
−75.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
16 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $53,020,253 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | −1,000,000 | 2,256,181 | $53,020,253 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 positions ·
$53,020,253 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 2,256,181 | $53,020,253 | 100.00% |